Co-Expression of Niemann-Pick Type C1-Like1 (NPC1L1) with ACE2 Receptor Synergistically Enhances SARS-CoV-2 Entry and Fusion.

MLA

Elste, James, et al. “Co-Expression of Niemann-Pick Type C1-Like1 (NPC1L1) with ACE2 Receptor Synergistically Enhances SARS-CoV-2 Entry and Fusion.” Biomedicines, vol. 12, no. 4, Apr. 2024, p. 821. EBSCOhost, https://doi.org/10.3390/biomedicines12040821.

APA

Elste, J., Cast, N., Udawatte, S., Adhikari, K., Payen, S. H., Verma, S. C., Shukla, D., Swanson-Mungerson, M., & Tiwari, V. (2024). Co-Expression of Niemann-Pick Type C1-Like1 (NPC1L1) with ACE2 Receptor Synergistically Enhances SARS-CoV-2 Entry and Fusion. Biomedicines, 12(4), 821. https://doi.org/10.3390/biomedicines12040821

Chicago

Elste, James, Nicole Cast, Shalini Udawatte, Kabita Adhikari, Shannon Harger Payen, Subhash C. Verma, Deepak Shukla, Michelle Swanson-Mungerson, and Vaibhav Tiwari. 2024. “Co-Expression of Niemann-Pick Type C1-Like1 (NPC1L1) with ACE2 Receptor Synergistically Enhances SARS-CoV-2 Entry and Fusion.” Biomedicines 12 (4): 821. doi:10.3390/biomedicines12040821.